De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function
Dorothea Gebert1, Matthias K Auer2, Mareike R Stieg2
1Research Group Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.
Abstract:
Despite the high prevalence of panhypopituitarism and diabetes insipidus in patients with craniopharyngioma (CP), little is known about the functioning of the neuropeptide oxytocin in these patients. This is of special interest as tumor-associated lesions often impair sites critical for oxytocin production and release, and affective dysfunction in CP links with elsewhere reported prosocial, antidepressant and anxiolytic oxytocin effects. Using a prospective study-design, we tested whether oxytocin is reduced in CP-patients, and whether altered oxytocin levels account for affective and emotional dysfunction. 26 adult CP-patients and 26 healthy controls matched in sex and age underwent physical exercise, a stimulus previously shown to induce oxytocin release. Baseline and stimulated salivary oxytocin levels, as well as empathy, depression and anxiety scores were measured. Results showed that patients overall did not present with lower baseline oxytocin levels than controls (F[1,30]=0.21, p=0.649), but baseline oxytocin levels were indeed reduced in patients with hypothalamic damage, as assessed by MRI-based grading (F[2,9.79]=4.54, p=0.040). In response to exercise-induced stimulation, all CP-patients showed a blunted oxytocin-release compared to controls (F[1,30]=9.36, p=0.005). DI was not associated with oxytocin levels. Regarding affective function, unexpectedly, higher baseline oxytocin was related to higher trait anxiety (b=2.885, t(43)=2.421, p=0.020, CI[.478; 5.292]); the positive link with higher depression failed to reach statistical significance (b=1.928, t(43)=1.949, p=0.058, CI[-0.070; 3.927]). A blunted oxytocin-release was linked with higher state anxiety (b=-0.133, t(43)=-2.797, p=0.008, CI[-0.230; -0.037]). Empathy was not associated with oxytocin measures. In conclusion, we observed reduced baseline oxytocin levels only in CP-patients with hypothalamic damage. Exercise-induced stimulation de-masked an oxytocin-deficiency in all CP-patients. Baseline oxytocin levels and stimulated OT-responses might have different effects on affective function, which should be considered in future substitution paradigms.
Insights
Craniopharyngioma patients show normal baseline oxytocin, but blunted release after exercise. Reduced oxytocin is linked to hypothalamic damage and anxiety in these patients.
Area of Science:
- Neuroendocrinology
- Neuropsychology
- Oncology
Background:
- Craniopharyngioma (CP) frequently causes panhypopituitarism and diabetes insipidus, impacting neuropeptide function.
- Oxytocin's roles in social behavior, mood, and anxiety suggest its relevance in CP patients with affective dysfunction.
- Tumor-related damage to critical brain regions may impair oxytocin production and release.
Purpose of the Study:
- To investigate oxytocin levels in adult patients with craniopharyngioma (CP).
- To determine if altered oxytocin levels correlate with affective and emotional dysfunction in CP patients.
- To assess oxytocin release in response to physical exercise as a stimulation method.
Main Methods:
- Prospective study involving 26 adult CP patients and 26 matched healthy controls.
- Measurement of baseline and exercise-stimulated salivary oxytocin levels.
- Assessment of empathy, depression, and anxiety using validated questionnaires; MRI for hypothalamic damage grading.
Main Results:
- CP patients did not show lower overall baseline oxytocin, but levels were reduced in those with hypothalamic damage.
- All CP patients exhibited a blunted oxytocin release in response to exercise compared to controls.
- Higher baseline oxytocin correlated with increased trait anxiety; blunted oxytocin release linked to higher state anxiety.
Conclusions:
- Oxytocin deficiency is unmasked by exercise-induced stimulation in CP patients, particularly those with hypothalamic damage.
- Baseline and stimulated oxytocin levels may differentially influence affective states like anxiety.
- Findings suggest considering oxytocin's complex role in CP patient care and potential therapeutic substitution paradigms.
More Related Videos
04:27Using Facial Electromyography to Assess Facial Muscle Reactions to Experienced and Observed Affective Touch in Humans
Published on: March 15, 2019
11:11Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
